Data from 28 states years found that NSAIDs and dermatological agents are seeing growth in spending.
Data from 28 states years found that NSAIDs and dermatological agents are seeing growth in spending.
According to the CWCI, reduced opioid utilization from 2010-2017 saved $6.5 billion in California comp costs.
An Oklahoma judge found the drug maker to be partially responsible for the harm of the opioid epidemic.
